|
1
|
Cho WC: Nasopharyngeal carcinoma:
Molecular biomarker discovery and progress. Mol Cancer.
(1)2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chou J, Lin YC, Kim J, You L, Xu Z, He B
and Jablons DM: Nasopharyngeal carcinoma - review of the molecular
mechanisms of tumorigenesis. Head Neck. 30:946–963. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Blanchard P, Lee A, Marguet S, Leclercq J,
Ng WT, Ma J, Chan AT, Huang PY, Benhamou E, Zhu G, et al: MAC-NPC
Collaborative Group. Chemotherapy and radiotherapy in
nasopharyngeal carcinoma: An update of the MAC-NPC meta-analysis.
Lancet Oncol. 16:645–655. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu
LZ, Sun Y, Lin AH, Liu MZ and Ma J: How does intensity-modulated
radiotherapy versus conventional two-dimensional radiotherapy
influence the treatment results in nasopharyngeal carcinoma
patients? Int J Radiat Oncol Biol Phys. 80:661–668. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Shukla GC, Singh J and Barik S: MicroRNAs:
Processing, maturation, target recognition and regulatory
functions. Mol Cell Pharmacol. 3:83–92. 2011.PubMed/NCBI
|
|
6
|
Iorio MV and Croce CM: Causes and
consequences of microRNA dysregulation. Cancer J. 18:215–222.
2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chen S, Li P, Li J, Wang Y, Du Y, Chen X,
Zang W, Wang H, Chu H, Zhao G, et al: MiR-144 inhibits
proliferation and induces apoptosis and autophagy in lung cancer
cells by targeting TIGAR. Cell Physiol Biochem. 35:997–1007.
2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL,
Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY, et al:
MicroRNA-144 promotes cell proliferation, migration and invasion in
nasopharyngeal carcinoma through repression of PTEN.
Carcinogenesis. 34:454–463. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bao H, Li X, Li H, Xing H, Xu B, Zhang X
and Liu Z: MicroRNA-144 inhibits hepatocellular carcinoma cell
proliferation, invasion and migration by targeting ZFX. J Biosci.
42:103–111. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liu F, Chen N, Xiao R, Wang W and Pan Z:
miR-144-3p serves as a tumor suppressor for renal cell carcinoma
and inhibits its invasion and metastasis by targeting MAP3K8.
Biochem Biophys Res Commun. 480:87–93. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mardilovich K, Pankratz SL and Shaw LM:
Expression and function of the insulin receptor substrate proteins
in cancer. Cell Commun Signal. 7(14)2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Taniguchi CM, Emanuelli B and Kahn CR:
Critical nodes in signalling pathways: Insights into insulin
action. Nat Rev Mol Cell Biol. 7:85–96. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
Chan SH, Kikkawa U, Matsuzaki H, Chen JH
and Chang WC: Insulin receptor substrate-1 prevents
autophagy-dependent cell death caused by oxidative stress in mouse
NIH/3T3 cells. J Biomed Sci. 19(64)2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bergmann U, Funatomi H, Kornmann M, Beger
HG and Korc M: Increased expression of insulin receptor substrate-1
in human pancreatic cancer. Biochem Biophys Res Commun.
220:886–890. 1996.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Shi B, Sepp-Lorenzino L, Prisco M, Linsley
P, deAngelis T and Baserga R: Micro RNA 145 targets the insulin
receptor substrate-1 and inhibits the growth of colon cancer cells.
J Biol Chem. 282:32582–32590. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wu X, Cui CL, Chen WL, Fu ZY, Cui XY and
Gong X: miR-144 suppresses the growth and metastasis of laryngeal
squamous cell carcinoma by targeting IRS1. Am J Transl Res. 8:1–11.
2016.PubMed/NCBI
|
|
17
|
Gao C and Chen YG: Dishevelled: The hub of
Wnt signaling. Cell Signal. 22:717–727. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang Y, Wang F, Han L, Wu Y, Li S, Yang
X, Wang Y, Ren F, Zhai Y, Wang D, et al: GABARAPL1 negatively
regulates Wnt/β-catenin signaling by mediating Dvl2 degradation
through the autophagy pathway. Cell Physiol Biochem. 27:503–512.
2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gao C, Cao W, Bao L, Zuo W, Xie G, Cai T,
Fu W, Zhang J, Wu W, Zhang X, et al: Autophagy negatively regulates
Wnt signalling by promoting Dishevelled degradation. Nat Cell Biol.
12:781–790. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Geng Y, Ju Y, Ren F, Qiu Y, Tomita Y,
Tomoeda M, Kishida M, Wang Y, Jin L, Su F, et al: Insulin receptor
substrate 1/2 (IRS1/2) regulates Wnt/β-catenin signaling through
blocking autophagic degradation of dishevelled2. J Biol Chem.
289:11230–11241. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tan G, Tang X and Tang F: The role of
microRNAs in nasopharyngeal carcinoma. Tumour Biol. 36:69–79.
2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Qiu F, Sun R, Deng N, Guo T, Cao Y, Yu Y,
Wang X, Zou B, Zhang S, Jing T, et al: miR-29a/b enhances cell
migration and invasion in nasopharyngeal carcinoma progression by
regulating SPARC and COL3A1 gene expression. PLoS One.
10(e0120969)2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Verhoeven RJ, Tong S, Zhang G, Zong J,
Chen Y, Jin DY, Chen MR, Pan J and Chen H: NF-κB signaling
regulates expression of Epstein-Barr virus BART MicroRNAs and long
noncoding RNAs in nasopharyngeal carcinoma. J Virol. 90:6475–6488.
2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wang S, Zhang R, Claret FX and Yang H:
Involvement of microRNA-24 and DNA methylation in resistance of
nasopharyngeal carcinoma to ionizing radiation. Mol Cancer Ther.
13:3163–3174. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Carew RM, Browne MB, Hickey FB and Brazil
DP: Insulin receptor substrate 2 and FoxO3a signalling are involved
in E-cadherin expression and transforming growth factor-β1-induced
repression in kidney epithelial cells. FEBS J. 278:3370–3380.
2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Sorokin AV and Chen J: MEMO1, a new
IRS1-interacting protein, induces epithelial-mesenchymal transition
in mammary epithelial cells. Oncogene. 32:3130–3138.
2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Dearth RK, Cui X, Kim HJ, Kuiatse I,
Lawrence NA, Zhang X, Divisova J, Britton OL, Mohsin S, Allred DC,
et al: Mammary tumorigenesis and metastasis caused by
overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2.
Mol Cell Biol. 26:9302–9314. 2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Karolina DS, Armugam A, Tavintharan S,
Wong MT, Lim SC, Sum CF and Jeyaseelan K: MicroRNA 144 impairs
insulin signaling by inhibiting the expression of insulin receptor
substrate 1 in type 2 diabetes mellitus. PLoS One.
6(e22839)2011.PubMed/NCBI View Article : Google Scholar
|
